文献速递前列腺增生与排尿功能障碍

经会阴前列腺激光消融术用于高手术风险且伴严重下尿路症状的良性前列腺梗阻患者

Trans - Perineal laser ablation of the prostate in high surgical risk patients affected by severe lower urinary tract symptoms related to benign prostatic obstruction.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2023-10-18

本研究前瞻性纳入40例高手术风险良性前列腺梗阻患者,评估经会阴前列腺激光消融术(TPLA®)的疗效与安全性。术后3、6个月前列腺体积和IPSS均较基线显著下降(p<0.001),23例留置膀胱造瘘管者中13例(56.5%)成功拔管;90天内19例(47.5%)出现至少一种手术并发症,无IV级或V级并发症。

要点

  • 40例高手术风险患者行TPLA®,中位年龄80岁,中位Charlson合并症指数6。
  • 术后3、6个月前列腺体积和IPSS均较基线显著下降(p<0.001)。
  • 永久膀胱造瘘管成功拔除13/23例(56.5%),90天内并发症以Clavien-Dindo I级为主。

核心结论

  • 经会阴前列腺激光消融术对高龄、高手术风险且伴严重良性前列腺梗阻患者是一种可行、安全、有效的微创手术技术。

研究设计与样本

  • 前瞻性研究,2020年10月至2022年6月连续纳入40例高手术风险良性前列腺梗阻患者;高手术风险定义为老年男性伴严重合并症,包括因既往用药或疾病导致的凝血问题。

主要发现

  • 中位(IQR)年龄80(72.5-84)岁,中位Charlson合并症指数6(5-7),中位前列腺体积38(30.5-73)cc。
  • 所有病例均在局部麻醉下完成TPLA®手术,并于手术当日出院。
  • 术后3个月和6个月中位前列腺体积较基线进行性缩小[38(30.5-73)vs 35(26-49)vs 34(28-49)cc,p<0.001]。
  • 中位IPSS相应改善[25(19-30)vs 10.5(7.5-13)vs 8(6-11.5),p<0.001]。
  • 23例永久膀胱造瘘管中13例(56.5%)成功拔除;术后90天内19例(47.5%)出现至少一种手术并发症,Clavien-Dindo I级16例(40%)、II级9例(22.5%)、III级1例(2.5%),未观察到IV级或V级并发症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In our study, we aimed to test the efficacy and safety of Trans-Perineal Laser Ablation of the prostate (TPLA®) in the surgical treatment of high-risk Benign Prostatic Obstruction (BPO) patients. METHODS: We defined a high-risk BPO patient as an elderly man affected by severe comorbidities, among which coagulation issues due to pre-existent medications or diseases. From October 2020 to June 2022, we prospectively enrolled high-risk patients affected by a moderate to severe and/or complicated BPO condition. The analysis of the efficacy of the Trans-Perineal Laser Ablation was defined as the primary endpoint of the study. Secondary endpoints were post-operative surgical complications and patient-reported quality of life. RESULTS: Globally, 40 consecutive patients were enrolled. Median (IQR) age was 80 (72.5-84) years. Median Charlson Comorbidity Index was 6 (5-7). Median prostate volume was 38 (30.5-73) cc. In all cases, a TPLA® procedure was performed under local anesthesia, and patients being discharged within the same day of the procedure. A progressive reduction of median prostate volumes was reported at 3 and 6 months post-operatively, compared to baseline [38 (30.5-73) vs 35 (26-49) vs 34 (28-49) cc, p < 0.001]. Median International Prostate Symptom Score (IPSS) improved accordingly [25 (19-30) vs 10.5 (7.5-13) vs 8 (6-11.5), p < 0.001]. A permanent bladder catheter was successfully removed in 13 out of 23 (56.5%) cases. Within 90 days from surgery, 19 (47.5%) patients experienced at least one surgical complication. According to the Clavien-Dindo classification, complications were classified as grade I in 16 (40%) cases, grade II in 9 (22.5%), and grade III in 1 (2.5%). We did not observe any grade IV or V complications. CONCLUSIONS: The Trans-Perineal Laser Ablation of the Prostate is a feasible, safe, and effective Minimally Invasive Surgical Technique, when offered to elderly, high-risk patients affected by severe Benign Prostatic Obstruction.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Destefanis P, Sibona M, Vitiello F, et al. Trans - Perineal laser ablation of the prostate in high surgical risk patients affected by severe lower urinary tract symptoms related to benign prostatic obstruction. Prostate Cancer Prostatic Dis. 2023. PMID: 37853099. doi:10.1038/s41391-023-00736-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。